SARS Coronavirus 2 Infection
2 clinical trials · Condition
◉ Watch SARS Coronavirus 2 Infection
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 (NCT04778059) | US Biotest, Inc. | 2021-07-27 |
| Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection) (NCT04361552) | Emory University | 2020-04-07 |
Track SARS Coronavirus 2 Infection automatically
Every clearance here is in the API, with alerts when new ones post.